Anzeige
Mehr »
Donnerstag, 26.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40P4H | ISIN: SE0023261292 | Ticker-Symbol: 5JD0
Frankfurt
26.06.25 | 08:08
2,160 Euro
+0,93 % +0,020
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXPRES2ION BIOTECH HOLDING AB Chart 1 Jahr
5-Tage-Chart
EXPRES2ION BIOTECH HOLDING AB 5-Tage-Chart

Aktuelle News zur EXPRES2ION BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiEXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Biotech Announces Pareto Securities Analyst Note on First Patient Dosed in Phase I Trial1
MoExpreS2ion Biotech Holding AB: ExpreS2ion announces dosing of first patient in Phase I clinical trial of ES2B-C001, its novel therapeutic breast cancer immunotherapy44Hørsholm, Denmark, 23 June 2025 - Today ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company"), a clinical-stage biotechnology company with a focused portfolio of immunotherapy candidates targeting...
► Artikel lesen
19.06.ExpreS2ion Biotech Holding AB: ExpreS2ion's associated company AdaptVac to lead CEPI and EU funded USD 12.4 million consortium to develop novel filovirus vaccine83Hørsholm, Denmark, 19 June 2025 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion") today announced that its associated company AdaptVac ApS ("AdaptVac"), of which...
► Artikel lesen
28.05.ExpreS2ion Biotech Holding AB: Bulletin from the Annual General Meeting of Expres2ion Biotech Holding AB held on 28 May 2025259The Annual General Meeting 2025 (the "AGM") of ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") was held today on 28 May 2025. Notice of the AGM and complete proposals for resolutions taken...
► Artikel lesen
23.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Biotech Announces Analysguiden Publishes Equity Research Report2
EXPRES2ION BIOTECH Aktie jetzt für 0€ handeln
21.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Biotech Announces Pareto Securities Analyst Update on Q1 2025 Results and Clinical Trial Progress1
15.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion announces financial results for the first quarter of 20252
13.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion files clinical trial amendment to enable combination testing of ES2B-C001 with antibody-drug conjugates and to expand the number of study sites3
09.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to Present in Upcoming Investor Events1
01.05.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion annual report for 2024 published1
24.04.EXPRES2ION BIOTECH HOLDING AB: Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)1
15.04.ExpreS2ion Biotech Holding AB: ExpreS2ion signs Letter of Intent with WuXi Vaccines to initiate technology evaluation of ExpreS2ion's proprietary production platform ExpreS2146Hørsholm, Denmark, 15 April 2025 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion"), today announced that ExpreS2ion and WuXi Vaccines have signed a Letter of...
► Artikel lesen
01.04.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Provides Pipeline Update2
31.03.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Announces Leadership Transition in R&D2
06.02.ExpreS2ion Biotech Holding AB: ExpreS2ion announces financial results for the fourth quarter of 2024227Hørsholm, Denmark, 6 February 2025 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2024. The report is available as an attachment...
► Artikel lesen
09.01.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to Present in Upcoming Investor and Scientific Events1
14.11.24ExpreS2ion Biotech Holding AB: ExpreS2ion announces financial results for the third quarter of 2024210Hørsholm, Denmark, 14 November 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachment...
► Artikel lesen
30.10.24XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.10.2024660The following instruments on XETRA do have their first trading 30.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.10.2024 Aktien 1 PLTRKPL00014 Trakcja S.A. 2 GB00BPVDXX64...
► Artikel lesen
29.10.24XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.10.2024662The following instruments on Boerse Frankfurt do have their last trading day on 29.10.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.10.2024.ISIN NameNO0012547308 STANDARD...
► Artikel lesen
29.10.24XFRA ISIN CHANGE337Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenNO0012547308 Standard Supply AS 29.10.2024 NO0013384651 Standard Supply AS 30.10.2024 Tausch 100:1US49372L1008 Kezar...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1